|
Jul 29
|
Thiogenesis Upsizes Fully Subscribed Non-Brokered Private Placement of Common Shares
|
|
Jul 22
|
Leigh Syndrome Market Research Report 2025-2035 | Competitive Analysis of PTC Therapeutics, Pharming Group, Edison Pharmaceuticals, Taysha Gene Therapies, and Thiogenesis Therapeutics
|
|
Jun 20
|
Thiogenesis Therapeutics to Present at UMDF's Mitochondrial Medicine 2025 Conference
|
|
Jun 17
|
Thiogenesis Announces Second Site Begins Enrolling in Phase 2 MELAS Clinical Trial and Provides Update
|
|
Feb 25
|
TSX Penny Stocks To Watch In February 2025
|
|
Feb 20
|
Thiogenesis Announces European Consulting and Investor Relations Agreement
|
|
Oct 9
|
Here's Why We're Watching Thiogenesis Therapeutics' (CVE:TTI) Cash Burn Situation
|
|
Dec 29
|
TSX Venture Exchange Stock Maintenance Bulletins
|
|
Dec 4
|
Thiogenesis CEO Invited to Lead a Round Table Discussion at Influential Mitochondria Symposium
|